Prince Courtney D, Rau Andrew R, Yorgason Jordan T, España Rodrigo A
Department of Neurobiology and Anatomy, Drexel University College of Medicine , Philadelphia, Pennsylvania 19129, United States.
ACS Chem Neurosci. 2015 Jan 21;6(1):138-46. doi: 10.1021/cn500246j. Epub 2014 Dec 11.
Extensive evidence suggests that the hypocretins/orexins influence cocaine reinforcement and dopamine signaling via actions at hypocretin receptor 1. By comparison, the involvement of hypocretin receptor 2 in reward and reinforcement processes has received relatively little attention. Thus, although there is some evidence that hypocretin receptor 2 regulates intake of some drugs of abuse, it is currently unclear to what extent hypocretin receptor 2 participates in the regulation of dopamine signaling or cocaine self-administration, particularly under high effort conditions. To address this, we examined the effects of hypocretin receptor 1, and/or hypocretin receptor 2 blockade on dopamine signaling and cocaine reinforcement. We used in vivo fast scan cyclic voltammetry to test the effects of hypocretin antagonists on dopamine signaling in the nucleus accumbens core and a progressive ratio schedule to examine the effects of these antagonists on cocaine self-administration. Results demonstrate that blockade of either hypocretin receptor 1 or both hypocretin receptor 1 and 2 significantly reduces the effects of cocaine on dopamine signaling and decreases the motivation to take cocaine. In contrast, blockade of hypocretin receptor 2 alone had no significant effects on dopamine signaling or self-administration. These findings suggest a differential involvement of the two hypocretin receptors, with hypocretin receptor 1 appearing to be more involved than hypocretin receptor 2 in the regulation of dopamine signaling and cocaine self-administration. When considered with the existing literature, these data support the hypothesis that hypocretins exert a permissive influence on dopamine signaling and motivated behavior via preferential actions on hypocretin receptor 1.
大量证据表明,下丘脑泌素/食欲素通过作用于下丘脑泌素受体1来影响可卡因强化作用和多巴胺信号传导。相比之下,下丘脑泌素受体2在奖赏和强化过程中的作用相对较少受到关注。因此,尽管有一些证据表明下丘脑泌素受体2调节某些滥用药物的摄取,但目前尚不清楚下丘脑泌素受体2在多大程度上参与多巴胺信号传导或可卡因自我给药的调节,特别是在高努力条件下。为了解决这个问题,我们研究了下丘脑泌素受体1和/或下丘脑泌素受体2阻断对多巴胺信号传导和可卡因强化作用的影响。我们使用体内快速扫描循环伏安法来测试下丘脑泌素拮抗剂对伏隔核核心区多巴胺信号传导的影响,并使用累进比率程序来研究这些拮抗剂对可卡因自我给药的影响。结果表明,阻断下丘脑泌素受体1或同时阻断下丘脑泌素受体1和2均可显著降低可卡因对多巴胺信号传导的影响,并降低服用可卡因的动机。相比之下,单独阻断下丘脑泌素受体2对多巴胺信号传导或自我给药没有显著影响。这些发现表明,两种下丘脑泌素受体的参与存在差异,下丘脑泌素受体1在多巴胺信号传导和可卡因自我给药的调节中似乎比下丘脑泌素受体2更重要。结合现有文献来看,这些数据支持以下假设:下丘脑泌素通过对下丘脑泌素受体1的优先作用,对多巴胺信号传导和动机行为产生允许性影响。